Fulgent Genetics, Inc.FLGTNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +8.10% | +13.92% | +15.17% | +17.18% | +9.34% |
| Gross Profit Growth | +26.24% | +28.24% | +29.99% | +32.65% | +2.30% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.96% | +3.57% | +2.44% | +1.09% | +0.41% |
| Weighted Average Shares Diluted Growth | +2.96% | +3.57% | +2.44% | +1.09% | +0.41% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +67.53% | -160.98% | -804.11% | +0.00% | -412.35% |
| Free Cash Flow Growth | +79.59% | -385.02% | +0.00% | +0.00% | -491.35% |
| Receivables Growth | +34.09% | +35.41% | +33.46% | +37.34% | +10.04% |
| Inventory Growth | +0.00% | +32.05% | +27.83% | +16.59% | -100.00% |
| Asset Growth | -1.24% | -1.96% | -2.63% | -1.56% | -0.53% |
| Book Value per Share Growth | -3.12% | -3.68% | -3.76% | -2.17% | -2.27% |
| Debt Growth | -44.48% | -38.23% | -40.18% | +1730.83% | -94.38% |
| R&D Expense Growth | +1.35% | +8.40% | -0.04% | +17.63% | +16.98% |
| SG&A Expenses Growth | -19.73% | +10.76% | +29.27% | +16.30% | +55.33% |